Literature DB >> 27986129

Ischemic Postconditioning Before Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction Reduces Contrast-induced Nephropathy and Improves Long-term Prognosis.

Yun-Yun Wang1, Tong Li2, Ying-Wu Liu1, Yu Wang1, Xiao-Min Hu1, Wen-Qing Gao1, Peng Wu1, Xin Li1, Wen-Jin Peng1, Wei Gao1, Guang-Dong Yu1, Bo-Jiang Liu1.   

Abstract

BACKGROUND AND AIMS: Contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) is one of the major adverse outcomes affecting the prognosis of patients with acute ST-segment elevation myocardial infarction (STEMI). Ischemic postconditioning prior to PCI (pre-PCI) in patients with STEMI is hypothesized to be protective against CIN after PCI.
METHODS: A total of 251 patients with STEMI were randomized into two groups: ischemic postconditioning group (n = 123, age, 61.1 ± 12.5 years) who underwent ischemic postconditioning prior to PCI; control group (n = 128; age, 64.1 ± 12.1 years) who underwent only PCI. Ischemic postconditioning was administered by three cycles of deflation and inflation of the balloon (1-min ischemia and 1-min reperfusion) starting 1 min after infarct-related artery (IRA) opening. Diagnostic criterion for CIN was: increase in serum creatinine level by ≥0.5 mg/dL or by ≥25% increase from preoperative level within 48 h of surgery. All patients were followed for 1 year for incidence of major cardiovascular events (MACE).
RESULTS: The incidence of postoperative CIN in the ischemic postconditioning group was 5.69% as compared to 14.06% in the control group (p <0.05). At one year, the MACE incidence in the ischemic postconditioning group was 7.32% as compared to 15.63% in the control group (p <0.05).
CONCLUSIONS: Pre-PCI ischemic postconditioning in STEMI patients significantly reduces the post-PCI incidence of CIN and improves long-term prognosis.
Copyright © 2016 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute myocardial infarction; Contrast-induced nephropathy; Ischemic postconditioning; Long term prognosis; Percutaneous coronary intervention

Mesh:

Substances:

Year:  2016        PMID: 27986129     DOI: 10.1016/j.arcmed.2016.10.001

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  2 in total

1.  Knockdown of MicroRNA-122 Protects H9c2 Cardiomyocytes from Hypoxia-Induced Apoptosis and Promotes Autophagy.

Authors:  Zaiwei Zhang; Hu Li; Shasha Chen; Ying Li; Zhiyuan Cui; Jie Ma
Journal:  Med Sci Monit       Date:  2017-09-05

2.  The Value of Serum YKL-40 and TNF-α in the Diagnosis of Acute ST-Segment Elevation Myocardial Infarction.

Authors:  Caoyang Fang; Zhenfei Chen; Jing Zhang; Jianyuan Pan; Xiaoqin Jin; Mengsi Yang; Luyao Huang
Journal:  Cardiol Res Pract       Date:  2022-08-23       Impact factor: 1.990

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.